WFH Advocates for Hemophilia Care Access at WHO EMRO Meeting in Cairo
World Federation of Hemophilia / Fédération mondiale de l’hémophilie posted on LinkedIn:
”During the 72nd Session of the WHO Regional Committee for the Eastern Mediterranean in Cairo, Egypt, WFH Regional Manager Rana Saifi delivered a statement advocating for the inclusion of hemophilia and other Bleeding Disorders in the WHO EMRO flagship initiative to expand access to quality medical products in the region.
This aligns with the recent WHO 2025 Essential Medicines List updates, a critical step forward that requires concrete regional and national action to ensure access to lifesaving treatments.
Saifi also voiced WFH’s strong support for a WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Inherited Bleeding Disorders, proposed for discussion at the 158th session of the WHO Executive Board and backed by several Member States including Armenia, Morocco, with support from Egypt, Nepal and Sri Lanka.
Read the full statement here.”
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis